Medication Guide
|
Site Map
|
Full Prescribing Information
Home
About GIST
SUTENT and GIST
Insurance help from First Resource
Tools for patients
Get a Treatment Partner
Use the Side Effect Guide
Get tips for living with GIST
Build a SUTENT calendar
Build a treatment team contact list
Build a prescription tracker
Build a resource guide
Tools for caregivers
Education and support
Important safety information
Get e-mail updates
Treating RCC with SUTENT
E-mail this page to a friend
Printer-friendly page
Back
Print
SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec
®
(imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.
Gleevec is a registered trademark of Novartis AG.
To create a customized SUTENT calendar, you must have Adobe
®
Flash
®
installed on your computer.
To get Adobe
®
Flash
®
now
click here
.
The Adobe
®
Web site is neither owned or controlled by Pfizer. Pfizer is not responsible for the content or services of this site.
Adobe
®
, the Adobe
®
logo, and Flash
®
are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.
To read or print the SUTENT prescribing information for patients or the full prescribing information, click the links below:
SUTENT prescribing information for patients
SUTENT Spanish prescribing information for patients
Full prescribing information
NEXT: Build a treatment team contact list